<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>contamination risk &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/contamination-risk/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Oct 2026 23:51:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>contamination risk &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Research report: Clinical validation of a vial wall-based dielectric barrier discharge plasma activation device for plasma-activated platelet-rich plasma preparation in osteoarthritis pain management</title>
		<link>https://bioengineer.org/research-report-clinical-validation-of-a-vial-wall-based-dielectric-barrier-discharge-plasma-activation-device-for-plasma-activated-platelet-rich-plasma-preparation-in-osteoarthritis-pain-management/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 23:51:13 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[biomedical device]]></category>
		<category><![CDATA[cartilage explants]]></category>
		<category><![CDATA[clinical feasibility study]]></category>
		<category><![CDATA[cold atmospheric plasma]]></category>
		<category><![CDATA[contamination risk]]></category>
		<category><![CDATA[dielectric barrier discharge]]></category>
		<category><![CDATA[growth factors]]></category>
		<category><![CDATA[Macrophage polarization]]></category>
		<category><![CDATA[mouse model]]></category>
		<category><![CDATA[osteoarthritis]]></category>
		<category><![CDATA[platelet-rich plasma]]></category>
		<category><![CDATA[reactive oxygen species]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=458679</guid>

					<description><![CDATA[A new dielectric barrier discharge device uses the wall of a sealed blood collection tube as its own plasma barrier, producing plasma-activated platelet-rich plasma with lower contamination risk, higher growth factor release, reduced cartilage damage in mice, and encouraging feasibility observations in a three-patient knee osteoarthritis study.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">458679</post-id>	</item>
	</channel>
</rss>
